149 related articles for article (PubMed ID: 25676843)
1. Osteosarcoma in Asian Populations Over the Age of 40 Years: A Multicenter Study.
Joo MW; Shin SH; Kang YK; Kawai A; Kim HS; Asavamongkolkul A; Jeon DG; Kim JD; Niu X; Tsuchiya H; Puri A; Wang EH; Chung SH; Chung YG
Ann Surg Oncol; 2015 Oct; 22(11):3557-64. PubMed ID: 25676843
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma after the age of fifty: A clinicopathological study.
Tempelaere C; Biau D; Babinet A; Anract P
Eur J Surg Oncol; 2019 Jul; 45(7):1288-1292. PubMed ID: 31014986
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma of the pelvis. Oncologic results of 40 patients.
Kawai A; Huvos AG; Meyers PA; Healey JH
Clin Orthop Relat Res; 1998 Mar; (348):196-207. PubMed ID: 9553553
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
6. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
7. Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high-grade osteosarcoma in patients aged 41-65 years.
Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Funauchi Y; Minami Y; Saito M; Okawa A
J Orthop Traumatol; 2020 Aug; 21(1):13. PubMed ID: 32865641
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.
Okada K; Hasegawa T; Nishida J; Ogose A; Tajino T; Osanai T; Yanagisawa M; Hatori M
Ann Surg Oncol; 2004 Nov; 11(11):998-1004. PubMed ID: 15525829
[TBL] [Abstract][Full Text] [Related]
9. The role of surgery and adjuvants to survival in Pagetic osteosarcoma.
Ruggieri P; Calabrò T; Montalti M; Mercuri M
Clin Orthop Relat Res; 2010 Nov; 468(11):2962-8. PubMed ID: 20652460
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant and neoadjuvant chemotherapy in osteosarcoma.
Bacci G; Lari S
Chir Organi Mov; 2001; 86(4):253-68. PubMed ID: 12056242
[TBL] [Abstract][Full Text] [Related]
12. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
14. Correlation between fluid-fluid levels on initial MRI and the response to chemotherapy in stage IIb osteosarcoma.
Jeon DG; Cho WH; Song WS; Kong CB; Cho SH; Lee JW; Lee SY
Ann Surg Oncol; 2014 Jun; 21(6):1956-62. PubMed ID: 24577812
[TBL] [Abstract][Full Text] [Related]
15. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
16. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
17. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
18. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma in Manitoba: review of 95 patients.
Huebert HT
Can J Surg; 1979 Nov; 22(6):564-8, 572. PubMed ID: 291464
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]